Enalapril/carvedilol for prevention of chemotherapy-induced heart failure: an end to the problem
- PMID: 24013049
- DOI: 10.1016/j.jacc.2013.06.059
Enalapril/carvedilol for prevention of chemotherapy-induced heart failure: an end to the problem
Comment in
-
Reply: Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies.J Am Coll Cardiol. 2013 Dec 24;62(25):2452. doi: 10.1016/j.jacc.2013.08.712. Epub 2013 Sep 4. J Am Coll Cardiol. 2013. PMID: 24013047 No abstract available.
Comment on
-
Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).J Am Coll Cardiol. 2013 Jun 11;61(23):2355-62. doi: 10.1016/j.jacc.2013.02.072. Epub 2013 Apr 10. J Am Coll Cardiol. 2013. PMID: 23583763 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
